# XURIDEN

NDC: 50633-330
Generic name: uridine triacetate
Labeler / Manufacturer: BTG International Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20240531

FDA application: NDA208169

## Active ingredients

- URIDINE TRIACETATE: 951 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50633-330"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50633-330
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88ca4d2b-3905-474b-9fd6-c81474f2fb4b